| Radiation induces proinflammatory dysbiosis: transmission of inflammatory susceptibility by host cytokine induction S Gerassy-Vainberg, A Blatt, Y Danin-Poleg, K Gershovich, E Sabo, ... Gut 67 (1), 97-107, 2018 | 272 | 2018 |
| Regulation of S100A8 stability by RNF5 in intestinal epithelial cells determines intestinal inflammation and severity of colitis YU Fujita, A Khateb, Y Li, R Tinoco, T Zhang, H Bar-Yoseph, MA Tam, ... Cell reports 24 (12), 3296-3311. e6, 2018 | 59 | 2018 |
| Murine genetic background has a stronger impact on the composition of the gut microbiota than maternal inoculation or exposure to unlike exogenous microbiota H Korach-Rechtman, S Freilich, S Gerassy-Vainberg, ... Applied and environmental microbiology 85 (18), e00826-19, 2019 | 55 | 2019 |
| Intestinal Dysbiosis in Carriers of Carbapenem-Resistant Enterobacteriaceae H Korach-Rechtman, M Hreish, C Fried, S Gerassy-Vainberg, ZS Azzam, ... Msphere 5 (2), 10.1128/msphere. 00173-20, 2020 | 27 | 2020 |
| Antibiotic use differentially affects the risk of anti-drug antibody formation during anti-TNFα therapy in inflammatory bowel disease patients: a report from the epi-IIRN Y Gorelik, S Freilich, S Gerassy-Vainberg, S Pressman, C Friss, A Blatt, ... Gut 71 (2), 287-295, 2022 | 25 | 2022 |
| A personalized network framework reveals predictive axis of anti-TNF response across diseases S Gerassy-Vainberg, E Starosvetsky, R Gaujoux, A Blatt, N Maimon, ... Cell Reports Medicine 5 (1), 2024 | 4 | 2024 |
| Intestinal dysbiosis in carbapenem-resistant Enterobacteriaceae carriers H Korach-Rechtman, M Hreish, C Fried, S Gerassy-Vainberg, ZS Azzam, ... bioRxiv, 855718, 2019 | 1 | 2019 |
| Method for determining suitability to anti-tnf alpha therapy SORR Shai, Y Chowers, S Gerassy-vainberg, A Blatt, E Starovetsky, ... US Patent App. 18/538,027, 2024 | | 2024 |
| Methods of assessing the therapeutic activity of agents for the treatment of immune disorders SS Shen-Orr, Y Chowers, A Alpert, S Gerassy-vainberg, E Feldman US Patent App. 18/033,582, 2024 | | 2024 |
| CytoPro: A computational platform for accurate and robust assessment of cell contributions in bulk expression from diverse tissues and conditions A Katz, R Gaujoux, H Orly, E Starosvetsky, R Rozov, Y Rabinovitch, ... bioRxiv, 2021.08. 19.456930, 2021 | | 2021 |
| DOP73 Antibiotic use differentially affects the risk of antidrug antibody formation during anti-TNFα therapy in Inflammatory Bowel Disease Y Gorelik, S Freilich, S Gerassy-Vainberg, A Blatt, S Pressman, G Focht, ... Journal of Crohn's and Colitis 15 (Supplement_1), S107-S108, 2021 | | 2021 |
| Assays for assessing neutralizing antibodies levels in subjects treated with a biological drug and uses thereof in personalized medicine Y Chowers, S Pressman, A Blatt, S Gerassy-vainberg US Patent App. 16/738,757, 2020 | | 2020 |
| OP33 Multi-omics analysis reveals specific bio-geographical and functional characteristics in inflammatory bowel disease intestinal mucosa N Maimon, S Gerassy-Vainberg, H Bar-Yosef, A Alpert, E Starosvetsky, ... Journal of Crohn's and Colitis 14 (Supplement_1), S031-S034, 2020 | | 2020 |
